Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, recently announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now available for all Tandem pump users and their HCPs in the United States, with international availability expected in 2024.
“The launch of Tandem Source offers new, easy-to-use reports and the consolidation of several platforms and features into a single, convenient location for all our customers’ needs,” said John Sheridan, president and CEO of Tandem Diabetes Care. “Feedback from early adopters of Tandem Source in the United States has been overwhelmingly positive, and we look forward to expanding access to other countries in the coming year.”
Tandem Source provides access to important therapy data as well as convenient ways for pump users to reorder supplies and update their pump software. For HCPs, Tandem Source provides the tools necessary to seamlessly view critical patient data, identify trends and help their patients better manage their diabetes. Both HCPs and pump users also have access to three new Tandem Source reports in the platform.
Tandem Source Highlights:
- A new web-based pump uploader offers faster data transfers to the cloud with no computer software to install or update.
- Automatic data transfers from users’ pumps using the t:connect mobile app keep online data current and remove the need for manual pump uploads.
- Three easy-to-use reports consolidate all the information needed for HCPs to make impactful clinical recommendations.
